BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen G, Yu M, Cao J, Zhao H, Dai Y, Cong Y, Qiao G. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Bioengineered 2021;12:5149-61. [PMID: 34384030 DOI: 10.1080/21655979.2021.1960775] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Dong Y, Sun X, Zhang K, He X, Zhang Q, Song H, Xu M, Lu H, Ren R. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression. Bioengineered 2021;12:12967-79. [PMID: 34939898 DOI: 10.1080/21655979.2021.2012069] [Reference Citation Analysis]
2 Wang S, Sun L. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway. Bioengineered 2021;12:8296-308. [PMID: 34565287 DOI: 10.1080/21655979.2021.1985346] [Reference Citation Analysis]
3 An L, Zhang J, Feng D, Zhao Y, Ouyang W, Shi R, Zhou X, Yu Z, Wei S, Min J, Wang H. KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer. Stem Cells Int 2021;2021:1434856. [PMID: 34650608 DOI: 10.1155/2021/1434856] [Reference Citation Analysis]